ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
64 hedge funds and large institutions have $123M invested in ChemoCentryx, Inc. in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 8 closing their positions.
559% more call options, than puts
Call options by funds: $455K | Put options by funds: $69K
5% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 19
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 66 → 64 (-2)
21% less capital invested
Capital invested by funds: $155M → $123M (-$32.5M)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Top Buyers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$2.56M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$2.19M |
| 3 |
GCM
Gruss Capital Management
New York
|
+$2.19M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$149K |
| 5 |
Millennium Management
New York
|
+$140K |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$1.32M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$575K |
| 3 |
Franklin Resources
San Mateo,
California
|
-$442K |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$280K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$237K |
CCXI Hedge Fund Activity: Q3 2014 in Review
64 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q3 2014, worth a combined $123M — down 21% from $155M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of CCXI and 6 opened new positions — a net loss of 2 holders — while 19 trimmed existing stakes and 20 added.
The largest buyer was Great Point Partners, opening a new position worth an estimated $2.56M. The largest seller was Broadfin Capital, cutting an estimated $1.32M.
- 64 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q3 2014, down from 66 in Q2 2014.
- Funds reported $123M of ChemoCentryx, Inc. stock for Q3 2014, down 21% quarter-over-quarter.
- 6 funds opened new ChemoCentryx, Inc. positions in Q3 2014 and 8 closed out, a net change of -2 holders.
- The largest ChemoCentryx, Inc. buyer in Q3 2014 was Great Point Partners, an estimated $2.56M added.
- The largest ChemoCentryx, Inc. seller in Q3 2014 was Broadfin Capital, an estimated $1.32M sold.
Based on aggregated 13F filings for Q3 2014.